{"id":"https://genegraph.clinicalgenome.org/r/06ff19da-e3d3-4bf8-8b84-7afe1d12ee4fv1.0","type":"EvidenceStrengthAssertion","dc:description":"MAOA was first associated with disease in 1993 in a large Dutch family with 14 individuals (consistent with X-linked inheritance) affected by Brunner syndrome.  Brunner syndrome is characterized by  borderline intellectual disability (ID), prominent behavioral abnormalities including aggressive and violent behavior, and  deficiency of monoamine oxidase A enzymatic activity as shown by Brunner et al in 1993 (PMIDs 8211186, 8503438). The gene-disease relationship includes case-level, segregation and experimental data. Loss of function variants in the MAOA coding region have been reported in at least 6 probands (3 nonsense, splice, frameshift and 3 missense) in 5 publications (PMIDs 8211186, 24169519, 25969726, 25807999, 29158550). Variants in this gene segregate with disease in at least 1 large family (PMID 8211186) and 2 siblings (PMID: 25969726, 25807999).The maximum genetic evidence score was reached after awarding missense variants with supporting biochemical evidence (loss of MAOA enzymatic activity) 1.5 points (equal to the number of points awarded to putative null variants), since deficiency of MAOA activity is a specific hallmark of loss of MAOA function. The gene-disease relationship is supported by a number of independent animal model studies including PMIDs 7792602 and 18418249. In summary, there is sufficient evidence to support definitive association between MAOA with Brunner syndrome. Although clinical diagnosis of Brunner syndrome is rare, the gene-disease association has been demonstrated in multiple reports and animal model studies that has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 1/15/20 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/06ff19da-e3d3-4bf8-8b84-7afe1d12ee4f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2020-04-14T20:39:50.820Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe6938a6-c5f7-4f8b-ad00-c56b51a03f45_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfc33c57-9908-40c7-a160-6d7f62781f19","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25807999","rdfs:label":"Family H:III-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":59,"detectionMethod":"X-chromosome exome","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"mild intellectual disability, obsessive behavior, limited friendships and were introverted and placid during clinical interview, Abnormal aggressive, impulsive or violent behavior","phenotypes":["obo:HP_0001256","obo:HP_0000722","obo:HP_0006919"],"previousTesting":true,"previousTestingDescription":"normal Karyotype, chromosomal microarray, fragile X, FRAXE PCR, 6 ID gene screen","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fe6938a6-c5f7-4f8b-ad00-c56b51a03f45_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25807999","allele":{"id":"https://genegraph.clinicalgenome.org/r/e0e1eccd-4b88-46df-b45f-39078bc7ee1c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000240.3(MAOA):c.749_750insT (p.Ser251fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA204423"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0c69cd79-1a17-4f84-9a71-b8146fd583b1_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7313e05f-9019-40af-9641-c392b9909f3a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25969726","rdfs:label":"ASD_16","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Autism spectrum disorder, moderate intellectual disability, mild psychosis, aggressive behavior, functional language impairment","phenotypes":["obo:HP_0002342","obo:HP_0000729"],"previousTesting":true,"previousTestingDescription":"fragile X testing and molecular karyotype with normal results","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0c69cd79-1a17-4f84-9a71-b8146fd583b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25969726","allele":{"id":"https://genegraph.clinicalgenome.org/r/27c2496b-75e1-4da3-96ce-518d0ae19fef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001270458.1(MAOA):c.1039-2A>G (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413010756"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/34187321-e7d0-4f22-8c40-c870cdd927cb_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e064db6-a359-4f10-82a6-b41680dceec0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8211186","rdfs:label":"proband_Brunner1993","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"X-chromosome linkage analysis. 26 polymorphisms tested. A maximum\nlod score of 2.64 with MAOA and of 2.54 with DXS17\nsuggested a localization of the defective gene in either\nproximal Xp or Xq13-22. Another four-point analysis ruled out Xq21-22 region and yielded a maximum lod score of 3.69 at the MAOA locus (Brunner et al., 1993 PMID:8503438)","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Borderline metal retardation, mild Intellectual disability, aggressive outbursts, anger, fear or frustration","phenotypes":["obo:HP_0006889","obo:HP_0001256","obo:HP_0006919"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/34187321-e7d0-4f22-8c40-c870cdd927cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8211186","allele":{"id":"https://genegraph.clinicalgenome.org/r/82ebeea0-0c31-465e-8da5-0fb6a3a06af6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000240.3(MAOA):c.886C>T (p.Gln296Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120852"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/998ece14-a7ab-42f3-9cb5-f3c0bfc0974f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Functional analysis of variant showed loss of function (reduced MAOA enzyme activity and protein level). Variant lose of function is consistent with Brunner syndrome.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/420f1299-489f-42d2-ac13-93908e98d561","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24169519","rdfs:label":"Patient III-1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":7,"detectionMethod":"Sequencing panel of 220 ID genes","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Autism, autoagression, stereotypies , behavioral abnormalities, delayed gross psychomotor skills (climb stairs and bicycle) and fine psychomotor skills (dressing and putting on shoes)","phenotypes":["obo:HP_0100716","obo:HP_0003745","obo:HP_0000708","obo:HP_0000729"],"previousTesting":true,"previousTestingDescription":"Normal karyotype and negative results from CGH array, Fragile X and ARX expansions testing","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/998ece14-a7ab-42f3-9cb5-f3c0bfc0974f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24169519","allele":{"id":"https://genegraph.clinicalgenome.org/r/522f53d2-9900-4c89-a817-bf06679aa701","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000240.3(MAOA):c.797G>T (p.Cys266Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA163205"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c626f7bd-cc04-4a12-8b58-0d7ac8c685e3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Urine sample analysis showed biochemical signature for MAOA deficiency, indicating loss of protein function due to the variant. Proband's phenotype (Brunner's syndrome) is also consistent with loss of function of the protein.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44b8be9b-c65c-4eae-8dff-e848d4fcefd8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25807999","rdfs:label":"Family R IV:5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sanger sequencing of MAOA gene","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"MildÂ Intellectual disability, ADHD, Abnormal aggressive, impulsive or violent behavior, history of impulsivity and aggressive outbursts with high thymine foods.","phenotypes":["obo:HP_0007018","obo:HP_0006919","obo:HP_0001256"],"previousTesting":true,"previousTestingDescription":"normal Chromosome microarray, fragile X PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c626f7bd-cc04-4a12-8b58-0d7ac8c685e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25807999","allele":{"id":"https://genegraph.clinicalgenome.org/r/9767dd2c-2c81-4853-be0e-ceb4abc66de6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000240.3(MAOA):c.133C>T (p.Arg45Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA204424"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/05b2d61b-4de0-41a5-a4ca-273c8ac2e09f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"no supporting biochemical evidence indicating MAOA deficiency is provided.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea91a153-4b63-4b3a-b847-e48bba8eb973","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29158550","rdfs:label":"Popp 2017: S_114","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Mild intellectual disability, speech delay, Behavioral anomalies","phenotypes":["obo:HP_0000708","obo:HP_0000750","obo:HP_0001256"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/05b2d61b-4de0-41a5-a4ca-273c8ac2e09f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29158550","allele":{"id":"https://genegraph.clinicalgenome.org/r/51b9aee0-d509-41cc-8188-b50bfc6e52c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000240.3(MAOA):c.730G>A (p.Val244Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413006738"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":3.1},{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e402dbc-c00b-4cd0-9095-8c87da781f37_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8211186","rdfs:label":"Family_Brunner1993","family":{"id":"https://genegraph.clinicalgenome.org/r/3e402dbc-c00b-4cd0-9095-8c87da781f37","type":"Family","rdfs:label":"Family_Brunner1993","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0e064db6-a359-4f10-82a6-b41680dceec0"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Borderline metal retardation, mild Intellectual disability, aggressive outbursts, anger, fear or frustration","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001256","obo:HP_0006919","obo:HP_0006889"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0e064db6-a359-4f10-82a6-b41680dceec0"},"publishedLodScore":3.55,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8.6},{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c26a01ff-a405-4410-8cc6-5b95fc15b558","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bead9691-665f-4233-8b36-888979083748","type":"Finding","dc:description":"maoa knock out mice exhibited several phenotypic features that resemble clinical feature of Brunner syndrome including  deficiency of MAOA enzyme activity, Abnormal aggressive, impulsive or violent behavior observed both in human","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7792602","rdfs:label":"Transgenic mice with MAOA exons 2-3 deletion","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/51b2462d-aaa5-4e3e-976f-a58fece786bc","type":"EvidenceLine","dc:description":"Score the same animal model described in greater detail by Bortolato M, et al., 2013, PMID: 22850464","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55ec2b7e-81a0-4b41-8375-0578351309cd","type":"Finding","dc:description":"deficiency of MAOA enzyme activity, aggressive behavior","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18418249","rdfs:label":"MAOA A863T KO mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1f6ef121-c995-4292-85d2-f9220c6d03b7","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a008f840-7ef1-4f5e-b32a-7a51bd1745ef","type":"Finding","dc:description":"MAOA deficient mice harboring premature termination codon showed social deficits and communication impairments. mutants do not show any alterations in learning, but do exhibit reduced learning reversal in the Morris Water maze. MAOA KO mice also exhibit sensory and motoric alterations akin to those observed in ASD, including impairments in gait, hearing and sensorimotor integration \n\nAbnormal aggressive, impulsive or violent behavior; Autistic behavior and monoamine oxidase A deficiency are characteristics of Brunner syndrome","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22850464","rdfs:label":"MAOA and MAOA/B KO mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/20ffc014-ef31-4693-91c4-424bbe1e48dd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ecc4acdb-123e-4390-930b-cf4d1146c3ec","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8098b883-cab1-4f0c-857c-b7f4da16e305","type":"Finding","dc:description":"Increased levels of MAOA substrates in maoa knock out mice indicates lack of enzyme activity which is consistent with Brunner syndrome in human","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9159177","rdfs:label":"levels of MAOA enzyme substrates in maoa kock out mice brain","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":76,"specifiedBy":"GeneValidityCriteria7","strengthScore":13.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Uw0yA4qO42M","type":"GeneValidityProposition","disease":"obo:MONDO_0010379","gene":"hgnc:6833","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_20ffc014-ef31-4693-91c4-424bbe1e48dd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}